Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus

Abstract

The aim of this research was to study the clinical features and microvascular complications risk factors of early-onset type 2 diabetes mellitus (T2DM). We analyzed the clinical data from 1421 T2DM inpatients at Wuhan Union Hospital. Subjects were divided into early-onset T2DM group (diagnostic age <40 years) and late-onset T2DM group (diagnostic age >40 years). All subjects underwent a standardized assessment of microvascular complications. Data were compared with independent-samples t test or Chi-square test. Multiple logistic regression was used to determine the risk factors of microvascular complications. Patients with early-onset T2DM were more inclined to have a lower systolic blood pressure (SBP), a longer duration of diabetes and higher levels of body mass index (BMI), uric acid (UA), fasting plasma glucose (FPG), total cholesterol (TC)- triglyceride (TG) and glycosylated hemoglobin (HbA1c) than those with late-onset T2DM (P<0.05). The prevalence of diabetic retinopathy (DR) was significantly higher and that of diabetic peripheral neuropathy (DPN) was significantly lower in early-onset group than in late-onset group (P<0.05). For DN, UA was an independent risk factor in early-onset T2DM. SBP and TG were independent risk factors in late-onset T2DM. For DR, duration of diabetes and SBP were independent risk factors in early-onset T2DM. Duration of diabetes, SBP and HbA1c were independent risk factors in late-onset T2DM. This study demonstrated that the clinical characteristics of early-onset T2DM were metabolic disorders, including glucose metabolism, lipid metabolism and amino acid metabolism. Early-onset T2DM was more likely to be associated with DR. The potential pathogenesis of early and late-onset T2DM might be different. The management of metabolic risk factors especially HbA1c, SBP, TG and UA is advised to be performed in the early stage of diabetes.

Keywords

early-onset type 2 diabetes mellitus / diabetic microvascular complication / diabetic nephropathy / diabetic retinopathy / diabetic peripheral neuropathy

References

[1] YangW, LuJ, WengJ, et al.. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12): 1090-1101

[2] WangL, GaoP, ZhangM, et al.. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24): 2515-2523

[3] ZouXT, ZhouXH, JiLN, et al.. The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Sci Rep, 2017, 7: 46534

[4] HillierTA, PedulaKL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care, 2001, 24(9): 1522-1527

[5] LiL, JiLN, GuoXH, et al.. Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetes. J Diabetes Complications, 2015, 29(1): 32-37

[6] SongSH, HardistyCA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years—clinical observation from a secondary care cohort. Q J Med, 2009, 102(11): 799-806

[7] ChanJC, LauES, LukAO, et al.. Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis. Am J Med, 2014, 127(7): 616-624

[8] SongSH. Emerging type 2 diabetes in young adults. Adv Exp Med Biol, 2012, 771: 51-61

[9] LukAOY, LauESH, SoWY, et al.. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes. Diabetes Care, 2014, 37(1): 149-157

[10] YeungRO, ZhangY, LukA, et al.. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol, 2014, 2(12): 935-943

[11] ChanJC, ChoNH, TajimaN, et al.. Diabetes in the western pacific region-past, present and future. Diabetes Res Clin Pract, 2014, 103(2): 244-255

[12] ReisJP, HankinsonAL, LoriaCM, et al.. Duration of abdominal obesity beginning in young adulthood and incident diabetes through middle age: The CARDIA study. Diabetes Care, 2013, 36(5): 1241-1247

[13] HuoX, GaoL, GuoL, et al.. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol, 2016, 4(2): 115-124

[14] MaRC, ChanJC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci, 2013, 1281: 64-91

[15] Lerman-GarberI, Aguilar-SalinasC, Tusié-LunaT, et al.. Early-onset type 2 diabetes mellitus. The experience from a third level medical institution. Gac Med Mex, 2010, 146(3): 179-184

[16] GungorN, ArslanianS. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr, 2004, 144(5): 656-659

[17] IrvingR, Tusié-LunaMT, MillsJ, et al.. Early onset type 2 diabetes in Jamaica and in Mexico. Opportunities derived from an interethnic study. Rev Invest Clin, 2011, 63(2): 198-209

[18] ChuangLM, SoegondoS, SoewondoP, et al.. Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res Clin Pract, 2006, 71(2): 146-155

[19] PradeepaR, AnjanaRM, UnnikrishnanR, et al.. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther, 2010, 12(10): 755-761

[20] GunathilakeW, SongS, SridharanS, et al.. Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes. QJM, 2010, 103(11): 881-884

[21] HuXX, GaoLL, GuoLX, et al.. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol, 2016, 4(2): 115-124

[22] LeRoithD, FonsecaV, VinikA. Metabolic memory in diabetes-focus on insulin. Diabetes Metab Res Rev, 2005, 21(2): 85-90

[23] AgrawalRP, SharmaP, PalM, et al.. Magnitude of dyslipedemia and its association with micro and macro vascular complications in type 2 diabetes: a hospital based study from Bikaner (Northwest India). Diabetes Res Clin Pract, 2006, 73(2): 211-214

[24] HinderLM, Vivekanandan-GiriA, McLeanLL, et al.. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol, 2013, 216(1): 1-11